Attestation committee
Accreditation committee
Expert committee
Dispositions, instructions
Normative acts
Nomenclature
Institutions
Scientific councils
Seminars
Theses
Scientific advisers
Scientists
Doctoral students
Postdoctoral students
CNAA logo

 română | русский | english


Revenco Valeriu, doctor habilitat, professorRevenco Valeriu, doctor habilitat, professor


Institution:State University of Medicine and Pharmacy "Nicolae Testemitanu"
Adviser Number:18 June, 2009, nr.962
Specialties: 14.00.06 - Cardiology and Reumatology

Thesis under consideration [4]

Dg Title Specialty Institution Role Defence date
D Induced codeposition of nanocrystalline Co-W coatings and their mechanical properties 02.00.05 Institute of Applied Phys... reviewer
adviser
Dicusar Alexandru
14.06.2012
D Angiotensin II receptor antagonist versus angiotensin-converting-enzyme inhibitor.: the impact on the interrelation between insulin-resistance and diastolic dysfunction in essential hypertension 14.00.06 Public Medico-Sanitary In... CSS member
adviser
Carauş Alexandru
04.07.2012
D Aspects of clinical course and risk factors of arterial hypertension in children 14.00.09 State University of Medic... consultant
adviser
Rudi Marcu
05.07.2012
D Optimization of pharmacotherapy of chronic heart failure by using losartan, lisinopril and their association 14.00.25 State University of Medic... reviewer
adviser
Gonciar Veaceslav
consultant
Butorov Ion
03.06.2015

Approved theses [5]

Dg Title Specialty Institution Role Approval date
DH Metabolic Syndrome: Peculiarities of Etiopathogenesis 14.00.05 consultant 06.10.2010
D Clinical-hemodynamic and biochemical aspects to the patients with arterial hypertension and obesity and the influence of imidazolinic I1 receptors agonist - monoxidine 14.00.06 State University of Medic... adviser 03.06.2010
D Particularities of cardiovascular pathology in systemic lupus erythematosus 14.00.06 adviser 01.10.2009
D Prevalenţa cardiopatiei ischemice şi a unor factori de risc în populaţia din oraşul Taiz (Republica Yemen) 14.00.06 adviser 23.02.2006
D Clinical-hemodynamic and biochemical aspects at the patients with arterial hypertension and obesity and the influence of selective β-adrenoblocant Nebivolol 14.00.06 adviser 22.09.2005